Talphera Inc (FRA:R5XA)
€ 0.46 0 (0%) Market Cap: 8.66 Mil Enterprise Value: -1.23 Mil PE Ratio: 0 PB Ratio: 0.89 GF Score: 39/100

Q4 2020 AcelRx Pharmaceuticals Inc Earnings Call Transcript

Mar 15, 2021 / 08:30PM GMT
Release Date Price: €36.09 (-2.41%)
Operator

Welcome to the AcelRx's Fourth Quarter and Full Year 2020 Conference Call. This call is being webcast live on the Events page of the Investor Relations section of AcelRx's website at acelrx.com. This call is the property of AcelRx and any recording, reproduction or transmission of this call without the express written consent of AcelRx is strictly prohibited. As a reminder, today's call is being recorded.

You may listen to a webcast replay of this call by going to the Investors Section of AcelRx's website.

I would now like to turn the call over to Raffi Asadorian, AcelRx's Chief Financial Officer. Please go ahead.

Raffi Mark Asadorian
AcelRx Pharmaceuticals, Inc. - CFO

Thank you for joining us this afternoon. Earlier today, we announced our previously released fourth quarter and full year 2020 financial results in a press release. This press release and the slide presentation accompanying this call are available in the Investors section of our website.

With me today is Dr. Pam Palmer, our Chief Medical Officer. Unfortunately, Vince

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot